Sharpe ratio
1.12Return earned for the risk taken.
Good
Good risk-adjusted returns. The fund has delivered strong returns for its level of risk.
+20.19%1Y Absolute Return
-0.21%1D
Loading NAV history…
Past performance is not an indicator of future returns.
Returns calculator comparison
Compare an illustrative investment outcome across return assumptions.
| Asset | Projected corpus | Total invested | Gain | Annual return |
|---|---|---|---|---|
| DSP Healthcare Fund - Direct Plan - GrowthFund 5Y annualised return | ₹11,27,744 | ₹7,32,612 | ₹3,95,132 | +17.18% |
| EPFIllustrative annual assumption | ₹8,95,132 | ₹7,32,612 | ₹1,62,520 | +8.25% |
| Residential propertyIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| PPFIllustrative annual assumption | ₹8,69,819 | ₹7,32,612 | ₹1,37,207 | +7.10% |
| Bank fixed depositIllustrative annual assumption | ₹8,56,981 | ₹7,32,612 | ₹1,24,369 | +6.50% |
| GoldIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| Savings accountIllustrative annual assumption | ₹7,86,827 | ₹7,32,612 | ₹54,215 | +3.00% |
Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.
Wealth multiple
₹1 became₹1.23
₹1 Lakh since launch₹1.23 Lakh
Fund age7.9 yrs
Fund information
Scheme code145454
ISININF740KA1LG1
BenchmarkBSE Healthcare TRI
CategoryEquity Scheme - Sectoral/ Thematic
Expense ratio0.74%
Exit loadExit load of 0.50% if redeemed within 1 month.
Minimum SIP₹100 SIP
Return comparison
60th / 932 in category| Period | Fund | Benchmark | Category avg |
|---|---|---|---|
| 1M | +131.49% | — | — |
| 3M | +13.57% | — | — |
| 6M | +37.82% | — | — |
| 1Y | +20.19% | — | +4.16% |
| 3Y | +21.75% | — | +12.54% |
| 5Y | +17.18% | — | +10.04% |
| Since Launch | +23.15% | — | — |
Risk-adjusted performance
Every measure is expanded with a plain-language reading of the latest calculated value.
Sortino ratio
1.65Return earned while limiting downside risk.
Good
Good downside protection with strong returns.
Standard deviation
12.70%How much the fund’s returns fluctuate over time.
Moderate volatility
Returns can move up and down noticeably.
Beta
—How closely the fund moves with the market.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Alpha
—Extra return generated above the benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Treynor ratio
—Return earned for each unit of market risk taken.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Calmar ratio
1.06How well the fund rewarded investors relative to its biggest decline.
Excellent
Excellent balance between returns and drawdowns.
Information ratio
—How consistently the fund outperformed its benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Portfolio allocation
Latest disclosed portfolio mix
Asset allocation
Allocation data has not been disclosed.
Market cap allocation
Sector allocation
Equity exposure by sector
Top holdings
10 of 32 disclosed positions
| Holding | Sector | Instrument type | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.42% |
| Ipca Laboratories Ltd | Healthcare | Equity | 8.17% |
| Cipla Ltd | Healthcare | Equity | 8.13% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 7.1% |
| Gland Pharma Ltd | Healthcare | Equity | 6.35% |
| Reverse Repo | Unspecified | Reverse Repo | 5.93% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.81% |
| Globus Medical Inc Forgn. Eq (GMED) | Healthcare | Foreign - Equity | 5.57% |
| Alkem Laboratories Ltd | Healthcare | Equity | 4.66% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 3.75% |
Fund management
CH
Chirag Dagli
Since 2020 · Prior to joining DSP Mutual Fund, he has worked with HDFC AMC, Aviva India Life Insurance Company Ltd., ICICI Securities Ltd., Pioneer Invest Corp, Deutsche Equities, Citigroup Global Markets.
Mr. Dagli has done B. COM and Chartered Accountant.
Compare similar funds
No comparable category funds are available yet.
Summary
A high-risk equity scheme - sectoral/ thematic fund. Ahead of its category average over 3Y by 9.2 points. Healthcare makes up 92% — trouble in that sector hits the whole fund.
Strengths
- Ahead of its category average over 3Y by 9.2 points.
- Turned every ₹1 into ₹5.2 since launch — compounding at 23.1% a year.
- Recovered from its worst fall in 1 months.
- Same fund manager for 6+ years — the strategy has not chopped and changed.
- Ranks 60 of 932 in its category over 1 year.
Weaknesses
- None
Ideal investor
- Needs a 5–7+ years horizon to ride out its high risk level.
- Good fit for SIPs — spreading purchases smooths out 12.7% volatility.
Risk drivers
- Healthcare makes up 92% — trouble in that sector hits the whole fund.